Literature DB >> 2262640

Nasal polyposis.

N Mygind.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2262640     DOI： 10.1016/s0091-6749(05)80142-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  12 in total

Review 1.  Nasal polyposis, eosinophil dominated inflammation, and allergy.

Authors:  N Mygind; R Dahl; C Bachert
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Human nasal polyp microenvironments maintained in a viable and functional state as xenografts in NOD-scid IL2rgamma(null) mice.

Authors:  Joel M Bernstein; Stephen P Brooks; Heather K Lehman; Liza Pope; Amy Sands; Leonard D Shultz; Richard B Bankert
Journal:  Ann Otol Rhinol Laryngol       Date:  2009-12       Impact factor: 1.547

3.  Eosinophils and mast cells: a comparison of nasal mucosa histology and cytology to markers in nasal discharge in patients with chronic sino-nasal diseases.

Authors:  Moritz Gröger; Andreas Bernt; Maria Wolf; Brigitte Mack; Elisabeth Pfrogner; Sven Becker; Matthias F Kramer
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-22       Impact factor: 2.503

4.  Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma.

Authors:  Mitsuteru Akahoshi; Kazuhiko Obara; Tomomitsu Hirota; Akira Matsuda; Koichi Hasegawa; Naomi Takahashi; Makiko Shimizu; Kazuko Nakashima; Lei Cheng; Satoru Doi; Hiroshi Fujiwara; Akihiko Miyatake; Kimie Fujita; Noritaka Higashi; Masami Taniguchi; Tadao Enomoto; Xiao-Quan Mao; Hitoshi Nakashima; Chaker N Adra; Yusuke Nakamura; Mayumi Tamari; Taro Shirakawa
Journal:  Hum Genet       Date:  2005-04-02       Impact factor: 4.132

Review 5.  Pharmacological management of nasal polyposis.

Authors:  Claus Bachert; Jean-Baptiste Watelet; Philippe Gevaert; Paul Van Cauwenberge
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  [Immunocytochemical detection of caspase 3 in various diseases of human nasal mucosa].

Authors:  R Hirt; F Paulsen; K Neumann; S Knipping
Journal:  HNO       Date:  2009-05       Impact factor: 1.284

7.  Expression of the cysteinyl leukotriene 1 receptor and glucocorticoid receptor-β in nasal polyps.

Authors:  Yong-Hwi An; Sung-Lyong Hong; Doo Hee Han; Chul Hee Lee; Yang-Gi Min; Chae-Seo Rhee
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-03       Impact factor: 2.503

8.  Hyaluronan synthases and hyaluronidases in nasal polyps.

Authors:  T Panogeorgou; E Tserbini; S Filou; D H Vynios; S S Naxakis; T A Papadas; P D Goumas; N S Mastronikolis
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12-10       Impact factor: 2.503

Review 9.  Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches.

Authors:  Atsushi Kato; Anju T Peters; Whitney W Stevens; Robert P Schleimer; Bruce K Tan; Robert C Kern
Journal:  Allergy       Date:  2021-09-15       Impact factor: 14.710

Review 10.  Superantigens and nasal polyps.

Authors:  Claus Bachert; Thibaut van Zele; Philippe Gevaert; Lore De Schrijver; Paul Van Cauwenberge
Journal:  Curr Allergy Asthma Rep       Date:  2003-11       Impact factor: 4.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.